Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 3
2020 6
2021 5
2022 3
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
When worlds collide: Th17 and Treg cells in cancer and autoimmunity.
Knochelmann HM, Dwyer CJ, Bailey SR, Amaya SM, Elston DM, Mazza-McCrann JM, Paulos CM. Knochelmann HM, et al. Cell Mol Immunol. 2018 May;15(5):458-469. doi: 10.1038/s41423-018-0004-4. Epub 2018 Mar 21. Cell Mol Immunol. 2018. PMID: 29563615 Free PMC article. Review.
Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma.
Liu S, Knochelmann HM, Lomeli SH, Hong A, Richardson M, Yang Z, Lim RJ, Wang Y, Dumitras C, Krysan K, Timmers C, Romeo MJ, Krieg C, O'Quinn EC, Horton JD, Dubinett SM, Paulos CM, Neskey DM, Lo RS. Liu S, et al. Among authors: knochelmann hm. Cell Rep Med. 2021 Oct 19;2(10):100411. doi: 10.1016/j.xcrm.2021.100411. eCollection 2021 Oct 19. Cell Rep Med. 2021. PMID: 34755131 Free PMC article. Clinical Trial.
Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell- and CXCR3-dependent manner.
Ware MB, Phillips M, McQuinn C, Zaidi MY, Knochelmann HM, Greene E, Robinson B, Herting CJ, Mace TA, Chen Z, Zhang C, Farren MR, Ruggieri AN, Bowers JS, Shakya R, Farris AB, Young G, Carson WE 3rd, El-Rayes B, Paulos CM, Lesinski GB. Ware MB, et al. Among authors: knochelmann hm. JCI Insight. 2023 Apr 24;8(8):e155006. doi: 10.1172/jci.insight.155006. JCI Insight. 2023. PMID: 36881480 Free PMC article.
Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines.
Dwyer CJ, Knochelmann HM, Smith AS, Wyatt MM, Rangel Rivera GO, Arhontoulis DC, Bartee E, Li Z, Rubinstein MP, Paulos CM. Dwyer CJ, et al. Among authors: knochelmann hm. Front Immunol. 2019 Feb 20;10:263. doi: 10.3389/fimmu.2019.00263. eCollection 2019. Front Immunol. 2019. PMID: 30842774 Free PMC article. Review.
The evolving landscape of immunotherapy in solid tumors.
Keilson JM, Knochelmann HM, Paulos CM, Kudchadkar RR, Lowe MC. Keilson JM, et al. Among authors: knochelmann hm. J Surg Oncol. 2021 Mar;123(3):798-806. doi: 10.1002/jso.26416. J Surg Oncol. 2021. PMID: 33595890 Free PMC article. Review.
Augmenting TCR signal strength and ICOS costimulation results in metabolically fit and therapeutically potent human CAR Th17 cells.
Wyatt MM, Huff LW, Nelson MH, Neal LR, Medvec AR, Rangel Rivera GO, Smith AS, Rivera Reyes AM, Knochelmann HM, Riley JL, Lesinski GB, Paulos CM. Wyatt MM, et al. Among authors: knochelmann hm. Mol Ther. 2023 Jul 5;31(7):2120-2131. doi: 10.1016/j.ymthe.2023.04.010. Epub 2023 Apr 20. Mol Ther. 2023. PMID: 37081789 Free PMC article.
Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy.
Rangel Rivera GO, Knochelmann HM, Dwyer CJ, Smith AS, Wyatt MM, Rivera-Reyes AM, Thaxton JE, Paulos CM. Rangel Rivera GO, et al. Among authors: knochelmann hm. Front Immunol. 2021 Mar 18;12:645242. doi: 10.3389/fimmu.2021.645242. eCollection 2021. Front Immunol. 2021. PMID: 33815400 Free PMC article. Review.
24 results